fda warning letter bpc-157 unapproved new drug Public advisory BPC-157 Just Cleared a Major

(b) Single small case series in knee pain A peer-reviewed article (Lee et al., Alternative Therapies in Health & Medicine , ~2021) describes: 12 patients with chronic knee pain Treated with intra-articular BPC-157, often combined with TB-500 7 of 12 reported symptom improvement lasting several months This study has major limitations: No control group No blinding No standardized outcomes (no KOOS, WOMAC, or imaging) Very small sample size Mixed interventions Conclusion: This study cannot demonstrate true benefit

Deficiency can lead to nervous, digestive, and reproductive system issues as well as a noticeable drop in energy levels

Notably, the enzyme has been linked to obesity and type 2 diabetes (T2D)

Mechanism Comparison Table Distinct Research Pathways The core difference between these two compounds comes down to where they act